BRCA1 and invasive ductal breast carcinoma: In addition to macroscopic changes in clinical manifestations, such as morbidity and prognosis in terms of tumor heterogeneity, tumors with BRCA1 mutation usually display invasive ductal carcinoma pathologically and have a higher incidence of myeloid carcinoma and atypical myeloid carcinoma [25].